Pavel Hoffmann

4.3k total citations · 1 hit paper
105 papers, 2.8k citations indexed

About

Pavel Hoffmann is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Pavel Hoffmann has authored 105 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cardiology and Cardiovascular Medicine, 28 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Physiology. Recurrent topics in Pavel Hoffmann's work include Cardiac Imaging and Diagnostics (27 papers), Acute Myocardial Infarction Research (18 papers) and Heart Rate Variability and Autonomic Control (14 papers). Pavel Hoffmann is often cited by papers focused on Cardiac Imaging and Diagnostics (27 papers), Acute Myocardial Infarction Research (18 papers) and Heart Rate Variability and Autonomic Control (14 papers). Pavel Hoffmann collaborates with scholars based in Norway, Sweden and Germany. Pavel Hoffmann's co-authors include Peter Thorén, John S. Floras, Douglas R. Seals, Michael Abdelnoor, Harald Arnesen, Sigrun Halvorsen, Siri Lagethon Heck, Berit Gravdehaug, Helge Røsjø and Jürgen Geisler and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Pavel Hoffmann

100 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

2016 440 citations Geeta Gulati, Siri Lagethon Heck et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pavel Hoffmann Norway	27	1.7k	554	383	371	317	105	2.8k
Sven V. Eriksson Sweden	27	784 0.5×	389 0.7×	204 0.5×	222 0.6×	823 2.6×	126	2.7k
Stuart D. Rosen United Kingdom	28	1.4k 0.9×	740 1.3×	328 0.9×	157 0.4×	370 1.2×	94	2.6k
Takashi Tarumi United States	38	1.6k 1.0×	753 1.4×	757 2.0×	100 0.3×	374 1.2×	172	4.1k
Angela J. Woodiwiss South Africa	39	2.6k 1.6×	249 0.4×	559 1.5×	145 0.4×	487 1.5×	238	5.0k
Attilio Parisi Italy	32	1.8k 1.1×	1.0k 1.8×	322 0.8×	178 0.5×	753 2.4×	141	3.5k
Jürgen Scharhag Germany	29	1.9k 1.1×	368 0.7×	600 1.6×	92 0.2×	173 0.5×	80	3.2k
Joseph Keul Germany	30	926 0.6×	103 0.2×	616 1.6×	950 2.6×	366 1.2×	56	3.7k
J. R. Hayes United Kingdom	24	692 0.4×	154 0.3×	696 1.8×	86 0.2×	503 1.6×	66	2.7k
James Oliver United Kingdom	12	1.3k 0.8×	220 0.4×	526 1.4×	38 0.1×	328 1.0×	22	2.5k
Wuwei Feng United States	33	430 0.3×	593 1.1×	216 0.6×	65 0.2×	255 0.8×	133	3.9k

Countries citing papers authored by Pavel Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Pavel Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Hoffmann more than expected).

Fields of papers citing papers by Pavel Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavel Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Hoffmann. The network helps show where Pavel Hoffmann may publish in the future.

Co-authorship network of co-authors of Pavel Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Hoffmann. A scholar is included among the top collaborators of Pavel Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Hoffmann. Pavel Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heck, Siri Lagethon, Anne Hansen Ree, Pavel Hoffmann, et al.. (2021). Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol. Circulation. 143(25). 2431–2440. 87 indexed citations

Hoffmann, Pavel, et al.. (2019). Safety and efficacy of hybrid vascular closure technique using both a suture‐ and collagen‐mediated closure device after transfemoral transcatheter aortic valve implantation. Catheterization and Cardiovascular Interventions. 95(6). 1171–1175. 4 indexed citations

Swanson, David, et al.. (2018). MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI. PLoS ONE. 13(11). e0206723–e0206723. 3 indexed citations

Hoffmann, Pavel, et al.. (2018). Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI. Journal of the American College of Cardiology. 72(2). 187–198. 46 indexed citations

Nordlund, David, Gert Klug, Einar Heiberg, et al.. (2016). Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction. European Heart Journal - Cardiovascular Imaging. 17(7). 744–753. 33 indexed citations

Elmula, Fadl Elmula M. Fadl, Pavel Hoffmann, Anne Cecilie K. Larstorp, et al.. (2014). Adjusted Drug Treatment Is Superior to Renal Sympathetic Denervation in Patients With True Treatment-Resistant Hypertension. Hypertension. 63(5). 991–999. 129 indexed citations

Elmula, Fadl Elmula M. Fadl, Pavel Hoffmann, Anne Cecilie K. Larstorp, Aud Høieggen, & Sverre E. Kjeldsen. (2014). ADJUSTED DRUG TREATMENT IS SUPERIOR TO RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH TRUE TREATMENT RESISTANT HYPERTENSION, A RANDOMIZED CLINICAL TRIAL. Journal of the American College of Cardiology. 63(12). A1306–A1306. 1 indexed citations

Heck, Siri Lagethon, Geeta Gulati, Anne Hansen Ree, et al.. (2012). Rationale and Design of the Prevention of Cardiac Dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial. Cardiology. 123(4). 240–247. 38 indexed citations

Mistry, Nisha, Michael Abdelnoor, Ingebjørg Seljeflot, et al.. (2011). Amino-Terminal Pro–B-Type Natriuretic Peptide (NT-proBNP) Levels 3 Months After Myocardial Infarction Are More Strongly Associated With Magnetic Resonance–Determined Ejection Fraction Than NTproBNP Levels in the Acute Phase. Journal of Cardiac Failure. 17(6). 479–486. 9 indexed citations

10.

Grøgaard, Haakon K., Svein Solheim, Ingebjørg Seljeflot, et al.. (2011). Circulating CD34⁺progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris. Scandinavian Journal of Clinical and Laboratory Investigation. 71(4). 322–329. 3 indexed citations

11.

Bøhmer, Ellen, Pavel Hoffmann, Michael Abdelnoor, Harald Arnesen, & Sigrun Halvorsen. (2009). Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances. Journal of the American College of Cardiology. 55(2). 102–110. 163 indexed citations

12.

Arnesen, Harald, et al.. (2009). The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina. Thrombosis Research. 124(5). 560–564. 16 indexed citations

13.

Gorczynski, Reginald M., Christian Alexander, Wolfgang G. Bessler, et al.. (2005). Analysis of interaction of cloned human and/or sheep fetal hemoglobin γ-chain and LPS in augmenting induction of inflammatory cytokine production in vivo and in vitro. Immunology Letters. 100(2). 120–129. 4 indexed citations

14.

Hoffmann, Pavel, et al.. (2000). The significance of intensity and duration of exercise on natural immunity in rats. Medicine & Science in Sports & Exercise. 32(11). 1908–1912. 7 indexed citations

15.

Ravery, V., et al.. (1998). Partial ureteral duplication in an inverted Y with epididymal ureteric ectopia and intrasinusal ureteral junction. Surgical and Radiologic Anatomy. 20(2). 135–138. 4 indexed citations

16.

Jónsdóttir, Ingibjörg H., C. Johansson, Alexzander Asea, et al.. (1997). Duration and mechanisms of the increased natural cytotoxicity seen after chronic voluntary exercise in rats. Acta Physiologica Scandinavica. 160(4). 333–339. 20 indexed citations

17.

Desgrandchamps, F., et al.. (1997). A comparative study of guidewire electrical resistance. British Journal of Urology. 80(3). 390–391. 2 indexed citations

18.

Asea, Alexzander, et al.. (1996). Natural immunity and chronic exercise in rats. The involvement of the spleen and the splenic nerves. Life Sciences. 58(23). 2137–2146. 10 indexed citations

19.

Persson, Stefan, Ingibjörg H. Jónsdóttir, Peter Thorén, et al.. (1993). Cerebrospinal fluid dynorphin-converting enzyme activity is increased by voluntary exercise in the spontaneously hypertensive rat. Life Sciences. 53(8). 643–652. 17 indexed citations

20.

Hoffmann, Pavel, Lars Terenius, & Peter Thorén. (1990). Cerebrospinal fluid immunoreactive β-endorphin concentration is increased by voluntary exercise in the spontaneously hypertensive rat. Regulatory Peptides. 28(2). 233–239. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact